Dealings in Listed Securities (Chapter 14 of Listing Requirements)
08/03/2022DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
SUNZEN BIOTECH BERHAD |
Subject | Dealings Outside Closed Period |
No | Salutation | Name | Designation | Description Of "Others" Designation |
DR |
FONG CHAN SENG |
Non-Executive Director |
||
Type of Transaction | Others | |||
Description of "Others" Type of Transaction | Exercise of Options | |||
Date of Transaction | 08 Mar 2022 | |||
Description of Securities |
Ordinary Shares |
|||
No of Securities Transacted | 400,000 | |||
% of Securities Transacted | 0.056 | |||
Consideration | Malaysian Ringgit (MYR) 0.139 | |||
MR |
PHANG TONG ENG |
Chief Financial Officer |
||
Type of Transaction | Others | |||
Description of "Others" Type of Transaction | Exercise of Options | |||
Date of Transaction | 08 Mar 2022 | |||
Description of Securities |
Ordinary Shares |
|||
No of Securities Transacted | 300,000 | |||
% of Securities Transacted | 0.042 | |||
Consideration | Malaysian Ringgit (MYR) 0.139 |
Announcement Info
Company Name | SUNZEN BIOTECH BERHAD |
Stock Name | SUNZEN |
Date Announced | 08 Mar 2022 |
Category | Dealings in Listed Securities (Chapter 14 of Listing Requirements) |
Reference Number | DLR-02032022-00021 |
Related Announcements for SUNZEN